Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496830

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496829

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496827

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496825

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496823

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496820

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496819

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496817

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496816

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496815

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496814

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496811

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496810

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496807

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Delivery Of Medicinal Products From The Group Medicines Available Under The Drug Program Drugs Used As Part Of Chemotherapy In The Entire Range Of Registered Indications And Purposes And In Indications Specific To The Clinical Condition Anticancer

Deadline: 24 Mar 2026

Poland

Ref. No.: 23496806

EMD:Ref Document

Bid Value: Ref Document

-5 Days Left

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Filter Your Search

FREE Trial plan for all new users!